-
Revance Therapeutics (NASDAQ:RVNC) Earns Hold Rating from Analysts at StockNews.com
Source: Buzz FX / 05 Jan 2025 02:41:14 America/New_York
Revance Therapeutics (NASDAQ:RVNC) Earns Hold Rating from Analysts at StockNews.com Written by MarketBeat January 5, 2025 Share Link copied to clipboard. StockNews.com assumed coverage on shares of Revance Therapeutics ( NASDAQ:RVNC - Get F
Read more...